Robert A. Blake

6.9k citations
34 papers · 2.5k · 1 hit paper · h-index 17

Impact in

Papers in

    • PI3K/AKT/mTOR signaling in cancer 6
    • Protein Degradation and Inhibitors 6
    • Ubiquitin and proteasome pathways 4
    • Protein Kinase Regulation and GTPase Signaling 4
    • Angiogenesis and VEGF in Cancer 3
    • Heat shock proteins research 3

Robert A. Blake

34 papers receiving 2.4k citations

Robert A. Blake's Hit Papers

SU6656, a Selective Src Family Kinase Inhibitor, Used To Probe Growth Factor Signaling 2000 · 532 citations
5320+8+17Years since publication100200300400500

Peers

Robert A. Blake
Comparison fields: 5 of 112
  • Hepatology 322
  • Immunology and Allergy 165
  • Oncology 601
  • Hematology 243
  • Molecular Biology 1.5k
Replace Marina Holgado-Madruga with:
Marina Holgado-Madruga United States
Takami Sato United States
Sándor Paku Hungary
Zijie Sun United States
Xiaoyan Zhou China
Adrian M. Jubb United Kingdom
P. Charles Lin United States
James M. Cleary United States
Youngchul Song United States
Dongsheng Gu China
Robert A. Blake relative to Marina Holgado-Madruga United States Marina Holgado-Madruga's profile →
Citations per field
00.5×2.5×
Marina Holgado-Madruga · 1×
Citations per year

Countries citing papers authored by Robert A. Blake

Since Specialization
Citations

This map shows the geographic impact of Robert A. Blake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Blake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Blake more than expected).

Fields of papers citing papers by Robert A. Blake

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Blake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Blake. The network helps show where Robert A. Blake may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert A. Blake, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert A. Blake Line = papers co-authored together Robert A. Blake links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.

#Work
1
SU6656, a Selective Src Family Kinase Inhibitor, Used To Probe Growth Factor Signaling
Hit paper breakdown →
2000532
2
A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo.
2003436
3
SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors.
2000426
4 2013262
5 1994127
6
Potent and selective inhibitors of the Met [hepatocyte growth factor/scatter factor (HGF/SF) receptor] tyrosine kinase block HGF/SF-induced tumor cell growth and invasion.
200397
7
Src family kinase activity is required for signal tranducer and activator of transcription 3 and focal adhesion kinase phosphorylation and vascular endothelial growth factor signaling in vivo and for anchorage-dependent and -independent growth of human tumor cells.
200394
8
Src promotes PKCdelta degradation.
199988
9 201769
10 200347
11 202045
12 200544
13 199429
14 200326
15 201126
16 201920
17 200620
18 202011
19 200411
20 202410

About Robert A. Blake

Robert A. Blake is a scholar working on Molecular Biology, Oncology, Genetics, Hematology and Organic Chemistry, having authored 34 papers that have together received 2.5k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (6 papers), Protein Degradation and Inhibitors (6 papers), Ubiquitin and proteasome pathways (4 papers), Protein Kinase Regulation and GTPase Signaling (4 papers), Estrogen and related hormone effects (3 papers), Angiogenesis and VEGF in Cancer (3 papers), Heat shock proteins research (3 papers) and Advanced Breast Cancer Therapies (3 papers). The work is most often cited by research in Hepatology (322 citations), Immunology and Allergy (165 citations), Oncology (601 citations), Hematology (243 citations) and Molecular Biology (1.5k citations). Robert A. Blake has collaborated with scholars based in United States, United Kingdom and Norway. Frequent co-authors include Li Sun, Sara A. Courtneidge, Martin A. Broome, Jianming Wu, Mikhail L. Gishizky, Xiangdong Liu, Julie M. Cherrington, Steve P. Watson, Alexander Laird and Gary L. Schieven. Their work appears in journals such as Cancer Research, Journal of Medicinal Chemistry, SLAS DISCOVERY, PLoS ONE and FEBS Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact